Edwards Lifesciences Change in Assets/Liabilities 2010-2025 | EW
Edwards Lifesciences annual/quarterly change in assets/liabilities history and growth rate from 2010 to 2025. Change in assets/liabilities can be defined as represents any other changes in assets/liabilities
- Edwards Lifesciences change in assets/liabilities for the quarter ending June 30, 2025 was $-0.076B, a 429.31% decline year-over-year.
- Edwards Lifesciences change in assets/liabilities for the twelve months ending June 30, 2025 was $-0.123B, a 69.85% decline year-over-year.
- Edwards Lifesciences annual change in assets/liabilities for 2024 was $-0.027B, a 88.49% decline from 2023.
- Edwards Lifesciences annual change in assets/liabilities for 2023 was $-0.236B, a 143.86% increase from 2022.
- Edwards Lifesciences annual change in assets/liabilities for 2022 was $-0.097B, a 814.15% increase from 2021.
| Edwards Lifesciences Annual Change in Assets/Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $-27 |
| 2023 | $-236 |
| 2022 | $-97 |
| 2021 | $-11 |
| 2020 | $-12 |
| 2019 | $37 |
| 2018 | $17 |
| 2017 | $5 |
| 2016 | $43 |
| 2015 | $6 |
| 2014 | $17 |
| 2013 | $8 |
| 2012 | $20 |
| 2011 | $19 |
| 2010 | $6 |
| 2009 | $8 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $47.690B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.932B | 22.37 |
| Intuitive Surgical (ISRG) | United States | $169.861B | 70.41 |
| IDEXX Laboratories (IDXX) | United States | $51.765B | 53.87 |
| Alcon (ALC) | Switzerland | $39.183B | 26.31 |
| IQVIA Holdings (IQV) | United States | $32.084B | 18.13 |
| DexCom (DXCM) | United States | $29.443B | 44.17 |
| Mettler-Toledo (MTD) | United States | $26.431B | 31.37 |
| STERIS (STE) | Ireland | $24.108B | 25.66 |
| Waters (WAT) | United States | $17.717B | 24.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.161B | 0.00 |
| Hologic (HOLX) | United States | $14.818B | 16.05 |
| Penumbra (PEN) | United States | $10.595B | 77.40 |
| Globus Medical (GMED) | United States | $8.256B | 19.04 |
| Sysmex ADR (SSMXY) | Japan | $8.070B | 25.64 |
| Masimo (MASI) | United States | $7.657B | 25.77 |
| Teleflex (TFX) | United States | $5.578B | 9.00 |
| Glaukos (GKOS) | United States | $5.538B | 0.00 |
| TransMedics (TMDX) | United States | $3.979B | 60.48 |
| Integer Holdings (ITGR) | United States | $3.762B | 18.77 |
| LivaNova (LIVN) | United Kingdom | $3.028B | 17.33 |
| Alphatec Holdings (ATEC) | United States | $2.372B | 0.00 |
| Veracyte (VCYT) | United States | $2.356B | 32.55 |
| PROCEPT BioRobotics (PRCT) | United States | $2.244B | 0.00 |
| Artivion (AORT) | United States | $2.067B | 104.31 |
| Nihon Kohden (NHNKY) | Japan | $1.940B | 23.16 |
| Elekta AB (EKTAY) | Sweden | $1.806B | 17.50 |
| Integra LifeSciences Holdings (IART) | United States | $1.156B | 6.62 |
| OPKO Health (OPK) | United States | $1.127B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.047B | 0.00 |
| IRadimed (IRMD) | United States | $0.929B | 45.07 |
| Beta Bionics (BBNX) | United States | $0.813B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.797B | 0.00 |
| AxoGen (AXGN) | United States | $0.746B | 0.00 |
| SiBone (SIBN) | United States | $0.717B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.582B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 9.73 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.467B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.453B | 3.64 |
| AngioDynamics (ANGO) | United States | $0.412B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.381B | 90.67 |
| RxSight (RXST) | United States | $0.374B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.371B | 9.43 |
| Spectral Diagnostics (EDTXF) | Canada | $0.305B | 0.00 |
| NeuroPace (NPCE) | United States | $0.301B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.294B | 20.26 |
| Alpha Tau Medical (DRTS) | Israel | $0.285B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.235B | 0.00 |
| Neuronetics (STIM) | United States | $0.227B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Inogen (INGN) | United States | $0.215B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.212B | 0.00 |
| CVRx (CVRX) | United States | $0.206B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.182B | 0.00 |
| Accuray (ARAY) | United States | $0.176B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.130B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.130B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.111B | 0.00 |
| InspireMD (NSPR) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.083B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.023B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.30 |